Identification of ANKRD13D as a potential target in renal cell carcinomas.
Wenqian ZhouYonghe HuangJing LiuYiguo LiuYuqing LiuChen YuPublished in: The International journal of biological markers (2024)
In conclusion, we identified ANKRD13D as a key immune regulator, and targeting ANKRD13D with immune checkpoints blockade may be a promoting strategy for renal cell carcinoma immunotherapy.